{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T07:16:01Z","timestamp":1787814961204,"version":"build-2784847793"},"reference-count":60,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2016,9,12]],"date-time":"2016-09-12T00:00:00Z","timestamp":1473638400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["EY019065"],"award-info":[{"award-number":["EY019065"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["EY021368"],"award-info":[{"award-number":["EY021368"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UL1 TR000062"],"award-info":[{"award-number":["UL1 TR000062"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["HL 7260-37"],"award-info":[{"award-number":["HL 7260-37"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["EY025465"],"award-info":[{"award-number":["EY025465"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ola B. Williams Foundation"},{"name":"Reseach to Prevent Blindness"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0162596","type":"journal-article","created":{"date-parts":[[2016,9,12]],"date-time":"2016-09-12T17:29:16Z","timestamp":1473701356000},"page":"e0162596","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":21,"title":["Histone Deacetylase Inhibition Restores Retinal Pigment Epithelium Function in Hyperglycemia"],"prefix":"10.1371","volume":"11","author":[{"given":"Danielle","family":"Desjardins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig E.","family":"Crosson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zsolt","family":"Ablonczy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,9,12]]},"reference":[{"key":"ref1","unstructured":"Prevention CfDCa. National Diabetes Statistics Report: Estimates of Diabetes and Its Burden in the United States. In: Services UDoHaH, editor. Atlanta, GA2014."},{"issue":"6","key":"ref2","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/S0161-6420(98)96025-0","article-title":"The 14-year incidence of visual loss in a diabetic population","volume":"105","author":"SE Moss","year":"1998","journal-title":"Ophthalmology"},{"issue":"10","key":"ref3","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1016\/S0161-6420(98)91020-X","article-title":"The Wisconsin epidemiologic study of diabetic retinopathy: XVII: The 14-year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes","volume":"105","author":"R Klein","year":"1998","journal-title":"Ophthalmology"},{"issue":"7","key":"ref4","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1185\/03007995.2010.482503","article-title":"Burden of illness of diabetic macular edema: literature review","volume":"26","author":"E Chen","year":"2010","journal-title":"Curr Med Res Opin"},{"issue":"6","key":"ref5","doi-asserted-by":"crossref","first-page":"98","DOI":"10.4239\/wjd.v2.i6.98","article-title":"Managing diabetic macular edema: The leading cause of diabetes blindness","volume":"2","author":"R-A Pedro","year":"2011","journal-title":"World J Diabetes"},{"key":"ref6","unstructured":"NEI N. Facts about diabetic eye disease 2015 [updated September 2015]. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/nei.nih.gov\/health\/diabetic\/retinopathy\" xlink:type=\"simple\">https:\/\/nei.nih.gov\/health\/diabetic\/retinopathy<\/ext-link>."},{"issue":"1","key":"ref7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.survophthal.2008.10.001","article-title":"Diabetic macular edema: pathogenesis and treatment","volume":"54","author":"N Bhagat","year":"2009","journal-title":"Surv Ophthalmol"},{"issue":"3","key":"ref8","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.ajpath.2013.05.017","article-title":"Inhibition of EGF signaling protects the diabetic retina from insulin-induced vascular leakage","volume":"183","author":"M Sugimoto","year":"2013","journal-title":"Am J Pathol"},{"issue":"9","key":"ref9","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1136\/bjo.2009.171702","article-title":"Insulin resistance and diabetic macular oedema in type 2 diabetes mellitus","volume":"94","author":"MA Zapata","year":"2010","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"ref10","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1136\/bjo.82.5.561","article-title":"VEGF localisation in diabetic retinopathy","volume":"82","author":"M Boulton","year":"1998","journal-title":"Br J Ophthalmol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"4","DOI":"10.2174\/1874364101307010004","article-title":"Diabetic retinopathy and VEGF","volume":"7","author":"N Gupta","year":"2013","journal-title":"Open Ophthalmol J"},{"issue":"3","key":"ref12","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.diabres.2007.10.018","article-title":"Relationship among VEGF, VEGF receptor, AGEs, and macrophages in proliferative diabetic retinopathy","volume":"79","author":"A Kakehashi","year":"2008","journal-title":"Diabetes Res Clin Pract"},{"issue":"3","key":"ref13","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1167\/iovs.06-0738","article-title":"RAGE ligand upregulation of VEGF secretion in ARPE-19 cells","volume":"48","author":"W Ma","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2014","key":"ref14","first-page":"486386","article-title":"Identification of chemokines and growth factors in proliferative diabetic retinopathy vitreous","volume":"2014","author":"Y Dai","year":"2014","journal-title":"Biomed Res Int"},{"issue":"4","key":"ref15","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1136\/bjo.80.4.363","article-title":"Levels of vascular endothelial growth factor are elevated in the vitreous of patients with subretinal neovascularisation","volume":"80","author":"J Wells","year":"1996","journal-title":"Br J Ophthalmol"},{"issue":"6","key":"ref16","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1136\/bjo.2004.055053","article-title":"Elevations of AGE and vascular endothelial growth factor with decreased total antioxidant status in the vitreous fluid of diabetic patients with retinopathy","volume":"89","author":"M Yokoi","year":"2005","journal-title":"Br J Ophthalmol"},{"issue":"6","key":"ref17","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.exer.2007.08.010","article-title":"VEGF modulation of retinal pigment epithelium resistance","volume":"85","author":"Z Ablonczy","year":"2007","journal-title":"Exp Eye Res"},{"issue":"4","key":"ref18","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1167\/iovs.13-13334","article-title":"Vascular endothelial growth factor modulates the function of the retinal pigment epithelium in vivo","volume":"55","author":"M Dahrouj","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"ref19","doi-asserted-by":"crossref","first-page":"e11383","DOI":"10.1371\/journal.pone.0011383","article-title":"Valproate administered after traumatic brain injury provides neuroprotection and improves cognitive function in rats","volume":"5","author":"P Dash","year":"2010","journal-title":"PloS One"},{"issue":"1","key":"ref20","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/jcbfm.2010.195","article-title":"Valproic acid attenuates blood-brain barrier disruption in a rat model of transient focal cerebral ischemia: the roles of HDAC and MMP-9 inhibition","volume":"31","author":"Z Wang","year":"2011","journal-title":"J Cereb Blood Flow Metab"},{"issue":"46","key":"ref21","doi-asserted-by":"crossref","first-page":"19599","DOI":"10.1073\/pnas.0907935106","article-title":"HDAC6 is a target for protection and regeneration following injury in the nervous system","volume":"106","author":"MA Rivieccio","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"ref22","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/nrd3674","article-title":"Epigenetic protein families: a new frontier for drug discovery","volume":"11","author":"C Arrowsmith","year":"2012","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"ref23","doi-asserted-by":"crossref","first-page":"E127","DOI":"10.1152\/ajpendo.00432.2009","article-title":"Transcriptional coactivator p300 regulates glucose-induced gene expression in endothelial cells","volume":"298","author":"S Chen","year":"2010","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"8","key":"ref24","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/(SICI)1521-1878(199808)20:8<615::AID-BIES4>3.0.CO;2-H","article-title":"Roles of histone acetyltransferases and deacetylases in gene regulation","volume":"20","author":"M Kuo","year":"1998","journal-title":"Bioessays"},{"issue":"12","key":"ref25","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.tips.2010.09.003","article-title":"Targeting the correct HDAC(s) to treat cognitive disorders","volume":"31","author":"A Fischer","year":"2010","journal-title":"Trends Pharmacol Sci"},{"issue":"4","key":"ref26","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.cell.2011.03.043","article-title":"Class IIa histone deacetylases are hormone-activated regulators of FOXO and mammalian glucose homeostasis","volume":"145","author":"MM Mihaylova","year":"2011","journal-title":"Cell"},{"issue":"6","key":"ref27","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1002\/jcb.22644","article-title":"Role of histone acetylation in the development of diabetic retinopathy and the metabolic memory phenomenon","volume":"110","author":"Q Zhong","year":"2010","journal-title":"J Cell Biochem"},{"issue":"17","key":"ref28","doi-asserted-by":"crossref","first-page":"18091","DOI":"10.1074\/jbc.M311786200","article-title":"In Vivo Chromatin Remodeling Events Leading to Inflammatory Gene Transcription under Diabetic Conditions","volume":"279","author":"F Miao","year":"2004","journal-title":"J Biol Chem"},{"issue":"9","key":"ref29","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.2337\/diacare.26.9.2653","article-title":"Diabetic retinopathy and diabetic macular edema pathophysiology, screening, and novel therapies","volume":"26","author":"TA Ciulla","year":"2003","journal-title":"Diabetes care"},{"issue":"10","key":"ref30","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1001\/jama.1993.03500100088034","article-title":"How effective are treatments for diabetic retinopathy?","volume":"269","author":"FL Ferris","year":"1993","journal-title":"JAMA"},{"issue":"2","key":"ref31","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.exer.2004.09.013","article-title":"Corticosteroids inhibit VEGF-induced vascular leakage in a rabbit model of blood\u2013retinal and blood\u2013aqueous barrier breakdown","volume":"80","author":"JL Edelman","year":"2005","journal-title":"Exp Eye Res"},{"issue":"8","key":"ref32","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1007\/s11892-014-0510-4","article-title":"Anti-VEGF therapy for diabetic macular edema","volume":"14","author":"MW Stewart","year":"2014","journal-title":"Curr Diab Rep"},{"issue":"12","key":"ref33","doi-asserted-by":"crossref","first-page":"8614","DOI":"10.1167\/iovs.11-8021","article-title":"Human retinal pigment epithelium cells as functional models for the RPE in vivo","volume":"52","author":"Z Ablonczy","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2015","key":"ref34","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.exer.2015.06.004","article-title":"Receptor mediated disruption of retinal pigment epithelium function in acute glycated-albumin exposure","volume":"137","author":"M Dahrouj","year":"2015","journal-title":"Exp Eye Res"},{"issue":"1","key":"ref35","doi-asserted-by":"crossref","first-page":"F14","DOI":"10.1152\/ajprenal.00200.2010","article-title":"The role of epigenetics in the pathology of diabetic complications","volume":"299","author":"LM Villeneuve","year":"2010","journal-title":"Am J Physiol Renal Physiol"},{"issue":"6","key":"ref36","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1167\/iovs.15-18397","article-title":"Progressive Early Breakdown of Retinal Pigment Epithelium Function in Hyperglycemic Rats","volume":"57","author":"DM Desjardins","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"ref37","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S0003-2697(03)00426-3","article-title":"Improved fluorogenic histone deacetylase assay for high-throughput-screening applications","volume":"321","author":"D Wegener","year":"2003","journal-title":"Anal Biochem"},{"issue":"31","key":"ref38","doi-asserted-by":"crossref","first-page":"10842","DOI":"10.1021\/ja102758v","article-title":"Rational design and simple chemistry yield a superior, neuroprotective HDAC6 inhibitor, tubastatin-A","volume":"132","author":"KV Butler","year":"2010","journal-title":"J Am Chem Soc"},{"issue":"5","key":"ref39","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1096\/fj.13-248021","article-title":"Progressive dysfunction of the retinal pigment epithelium and retina due to increased VEGF-A levels","volume":"28","author":"Z Ablonczy","year":"2014","journal-title":"FASEB J"},{"issue":"3","key":"ref40","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jconrel.2008.05.010","article-title":"Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles","volume":"132","author":"F Kratz","year":"2008","journal-title":"J Control Release"},{"issue":"23","key":"ref41","doi-asserted-by":"crossref","first-page":"8035","DOI":"10.1128\/MCB.21.23.8035-8044.2001","article-title":"Identification of components of the murine histone deacetylase 6 complex: link between acetylation and ubiquitination signaling pathways","volume":"21","author":"D Seigneurin-Berny","year":"2001","journal-title":"Mol Cell Biol"},{"issue":"6","key":"ref42","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.tcb.2008.04.003","article-title":"HDAC6: a key regulator of cytoskeleton, cell migration and cell-cell interactions","volume":"18","author":"A Valenzuela-Fern\u00e1ndez","year":"2008","journal-title":"Trends Cell Biol"},{"issue":"6887","key":"ref43","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/417455a","article-title":"HDAC6 is a microtubule-associated deacetylase","volume":"417","author":"C Hubbert","year":"2002","journal-title":"Nature"},{"issue":"2013","key":"ref44","first-page":"665","article-title":"Review: Epigenetic mechanisms in ocular disease","volume":"19","author":"S He","year":"2013","journal-title":"Mol Vis"},{"issue":"2007","key":"ref45","doi-asserted-by":"crossref","first-page":"31867","DOI":"10.1155\/2007\/31867","article-title":"Cellular signaling and potential new treatment targets in diabetic retinopathy","volume":"2007","author":"ZA Khan","year":"2007","journal-title":"Exp Diabetes Res"},{"issue":"3\u20134","key":"ref46","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1023\/A:1002192829817","article-title":"Mechanisms of fluid accumulation in retinal edema","volume":"97","author":"M Marmor","year":"1999","journal-title":"Doc Ophthalmol"},{"issue":"2010","key":"ref47","first-page":"190724","article-title":"The retinal pigment epithelium: something more than a constituent of the blood-retinal barrier\u2014implications for the pathogenesis of diabetic retinopathy","volume":"2010","author":"R Sim\u00f3","year":"2010","journal-title":"J Biomed Biotechnol"},{"issue":"5","key":"ref48","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.molcel.2005.04.021","article-title":"HDAC6 regulates Hsp90 acetylation and chaperone-dependent activation of glucocorticoid receptor","volume":"18","author":"JJ Kovacs","year":"2005","journal-title":"Mol Cell"},{"issue":"13","key":"ref49","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1186\/1471-2164-13-709","article-title":"Pan-histone deacetylase inhibitors regulate signaling pathways involved in proliferative and pro-inflammatory mechanisms in H9c2 cells","volume":"18","author":"G Majumdar","year":"2012","journal-title":"BMC Genomics"},{"issue":"24","key":"ref50","doi-asserted-by":"crossref","first-page":"6820","DOI":"10.1093\/emboj\/cdf682","article-title":"In vivo destabilization of dynamic microtubules by HDAC6-mediated deacetylation","volume":"21","author":"A Matsuyama","year":"2002","journal-title":"The EMBO journal"},{"issue":"2","key":"ref51","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s10456-007-9067-z","article-title":"Vascular permeability in ocular disease and the role of tight junctions","volume":"10","author":"KK Erickson","year":"2007","journal-title":"Angiogenesis"},{"issue":"7","key":"ref52","doi-asserted-by":"crossref","first-page":"e101815","DOI":"10.1371\/journal.pone.0101815","article-title":"Downregulation of Blood-Brain Barrier Phenotype by Proinflammatory Cytokines Involves NADPH Oxidase-Dependent ROS Generation: Consequences for Interendothelial Adherens and Tight Junctions","volume":"9","author":"KD Rochfort","year":"2014","journal-title":"PloS one"},{"issue":"12","key":"ref53","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1158\/1541-7786.692.2.12","article-title":"Histone deacetylase inhibitors up-regulate the expression of tight junction proteins","volume":"2","author":"M Bordin","year":"2004","journal-title":"Mol Cancer Res"},{"issue":"3","key":"ref54","doi-asserted-by":"crossref","first-page":"C245","DOI":"10.1152\/ajpcell.00336.2013","article-title":"Microtubules are required for efficient epithelial tight junction homeostasis and restoration","volume":"307","author":"LA Glotfelty","year":"2014","journal-title":"Am J Physiol Cell Physiol"},{"issue":"5","key":"ref55","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1083\/jcb.105.5.2167","article-title":"Posttranslational modification and microtubule stability","volume":"105","author":"E Schulze","year":"1987","journal-title":"J Cell Biol"},{"issue":"2","key":"ref56","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1083\/jcb.104.2.289","article-title":"Microtubules containing acetylated alpha-tubulin in mammalian cells in culture","volume":"104","author":"G Piperno","year":"1987","journal-title":"J Cell Biol"},{"issue":"Pt 1","key":"ref57","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1242\/jcs.92.1.57","article-title":"Microtubules are acetylated in domains that turn over slowly","volume":"92","author":"DR Webster","year":"1989","journal-title":"J Cell Sci"},{"issue":"2","key":"ref58","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.yexmp.2015.01.003","article-title":"Sodium valproate ameliorates diabetes-induced fibrosis and renal damage by the inhibition of histone deacetylases in diabetic rat","volume":"98","author":"K Sabbir","year":"2015","journal-title":"Exp Mol Pathol"},{"issue":"20","key":"ref59","first-page":"1411","article-title":"Effects of 5-aza-2&apos;-deoxycytidine and trichostatin-A on high glucose- and interleukin-1\u03b2-induced secretory mediators from human retinal endothelial cells and retinal pigment epithelial cells","volume":"27","author":"M Xie","year":"2014","journal-title":"Mol Vis"},{"issue":"3","key":"ref60","doi-asserted-by":"crossref","first-page":"e0120587","DOI":"10.1371\/journal.pone.0120587","article-title":"Attenuation of choroidal neovascularization by histone deacetylase inhibitor","volume":"10","author":"N Chan","year":"2015","journal-title":"PloS one"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0162596","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T09:39:39Z","timestamp":1718789979000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0162596"}},"subtitle":[],"editor":[{"given":"Michael E","family":"Boulton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,9,12]]},"references-count":60,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2016,9,12]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0162596","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,12]]}}}